F. De Benedetti Et Al. , "Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD and TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial," ARTHRITIS & RHEUMATOLOGY , vol.69, pp.22-23, 2017
De Benedetti, F. Et Al. 2017. Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD and TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial. ARTHRITIS & RHEUMATOLOGY , vol.69 , 22-23.
De Benedetti, F., Anton, J., Ben-Chetrit, E., Calvo, I., Frenkel, J., Gattorno, M., ... Hoffman, H. M.(2017). Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD and TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial. ARTHRITIS & RHEUMATOLOGY , vol.69, 22-23.
De Benedetti, Fabrizio Et Al. "Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD and TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial," ARTHRITIS & RHEUMATOLOGY , vol.69, 22-23, 2017
De Benedetti, Fabrizio D. Et Al. "Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD and TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial." ARTHRITIS & RHEUMATOLOGY , vol.69, pp.22-23, 2017
De Benedetti, F. Et Al. (2017) . "Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD and TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial." ARTHRITIS & RHEUMATOLOGY , vol.69, pp.22-23.
@article{article, author={Fabrizio De Benedetti Et Al. }, title={Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD and TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2017, pages={22-23} }